Related Experiment Videos
Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model
C S McLean1, J S Sterling, J Mowat
1Department of Pathology, University of Cambridge, U.K.
The Journal of General Virology
|February 1, 1993
Summary
Researchers developed a mouse model to study immune responses to human papillomavirus type 16 (HPV-16). They observed a specific CD4+ T-cell mediated delayed-type hypersensitivity response to the HPV-16 E7 protein.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Human papillomavirus type 16 (HPV-16) is a major cause of cervical cancer.
- The E7 oncoprotein of HPV-16 is a key target for anti-tumor immunity.
- Understanding the immune response to HPV-16 is crucial for vaccine development.
Purpose of the Study:
- To develop a preclinical mouse model to study the immune response to HPV-16.
- To investigate the cellular mechanisms underlying the immune response to HPV-16 E7 protein.
Main Methods:
- A mouse keratinocyte cell line expressing the HPV-16 E7 protein was established.
- The cell line was grafted onto syngeneic mice to create a differentiated epithelium.
- A delayed-type hypersensitivity (DTH) assay was performed using a vaccinia virus recombinant expressing E7.
Main Results:
- A DTH response was successfully induced in the mouse model after challenge with E7.
- The observed DTH response was specific to the E7 polypeptide.
- The immune response was mediated by CD4+ T-cells.
Conclusions:
- The developed mouse model effectively mimics natural HPV-16 infection and allows for the study of anti-tumor immunity.
- CD4+ T-cells play a critical role in the immune response to HPV-16 E7.
- This model provides a valuable platform for evaluating therapeutic strategies against HPV-16-induced cancers.